These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19413351)

  • 21. Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization.
    Navarro P; Ruco L; Dejana E
    J Cell Biol; 1998 Mar; 140(6):1475-84. PubMed ID: 9508779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and function of fibrinogen BβN-domains.
    Medved L; Yakovlev S
    Ukr Biochem J; 2020; 92(3):22-32. PubMed ID: 37986735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Basis for the Interaction of Fibrin with the Very Low-Density Lipoprotein Receptor Revealed by NMR and Site-Directed Mutagenesis.
    Gruschus JM; Yakovlev S; Banerjee K; Medved L; Tjandra N
    Biochemistry; 2021 Aug; 60(33):2537-2548. PubMed ID: 34351135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of the fibronectin COOH-terminal Fib-2 regions with fibrin: further characterization and localization of the Fib-2-binding sites.
    Makogonenko E; Ingham KC; Medved L
    Biochemistry; 2007 May; 46(18):5418-26. PubMed ID: 17425334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Location of plasminogen-binding sites in human fibrin(ogen).
    Váradi A; Patthy L
    Biochemistry; 1983 May; 22(10):2440-6. PubMed ID: 6222763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor XIIIa incorporates thymosin beta4 preferentially into the fibrin(ogen) alphaC-domains.
    Makogonenko E; Goldstein AL; Bishop PD; Medved L
    Biochemistry; 2004 Aug; 43(33):10748-56. PubMed ID: 15311936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of fibrin(ogen) with leukocyte receptor alpha M beta 2 (Mac-1): further characterization and identification of a novel binding region within the central domain of the fibrinogen gamma-module.
    Yakovlev S; Zhang L; Ugarova T; Medved L
    Biochemistry; 2005 Jan; 44(2):617-26. PubMed ID: 15641787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic Regulation of Vascular Permeability by Vascular Endothelial Cadherin-Mediated Endothelial Cell-Cell Junctions.
    Rho SS; Ando K; Fukuhara S
    J Nippon Med Sch; 2017; 84(4):148-159. PubMed ID: 28978894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual functions of the fibrin βN-domains in the VLDL receptor-dependent pathway of transendothelial migration of leukocytes.
    Yakovlev S; Medved L
    Thromb Res; 2022 Jun; 214():1-7. PubMed ID: 35421681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining the molecular basis of interaction between R3 receptor-type protein tyrosine phosphatases and VE-cadherin.
    Dorofejeva O; Barr AJ
    PLoS One; 2017; 12(9):e0184574. PubMed ID: 28926625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels.
    Bach TL; Barsigian C; Chalupowicz DG; Busler D; Yaen CH; Grant DS; Martinez J
    Exp Cell Res; 1998 Feb; 238(2):324-34. PubMed ID: 9473340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) alpha C-domains.
    Tsurupa G; Medved L
    Biochemistry; 2001 Jan; 40(3):801-8. PubMed ID: 11170397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other.
    Litvinov RI; Yakovlev S; Tsurupa G; Gorkun OV; Medved L; Weisel JW
    Biochemistry; 2007 Aug; 46(31):9133-42. PubMed ID: 17630702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.
    Schulz B; Pruessmeyer J; Maretzky T; Ludwig A; Blobel CP; Saftig P; Reiss K
    Circ Res; 2008 May; 102(10):1192-201. PubMed ID: 18420943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of fibrin(ogen) with apolipoprotein(a): further characterization and identification of a novel lysine-dependent apolipoprotein(a)-binding site within the gamma chain 287-411 region.
    Tsurupa G; Yakovlev S; Pechik I; Lamanuzzi LB; Anglés-Cano E; Medved L
    Biochemistry; 2006 Sep; 45(35):10624-32. PubMed ID: 16939214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis.
    Flemming S; Burkard N; Renschler M; Vielmuth F; Meir M; Schick MA; Wunder C; Germer CT; Spindler V; Waschke J; Schlegel N
    Cardiovasc Res; 2015 Jul; 107(1):32-44. PubMed ID: 25975259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distal interactions within the par3-VE-cadherin complex.
    Tyler RC; Peterson FC; Volkman BF
    Biochemistry; 2010 Feb; 49(5):951-7. PubMed ID: 20047332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmalemmal concentration and affinity of mouse vascular endothelial cadherin, VE-cadherin.
    Baumgartner W; Drenckhahn D
    Eur Biophys J; 2002 Dec; 31(7):532-8. PubMed ID: 12451422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of initiation of fibrinolysis by fibrin.
    Medved L; Nieuwenhuizen W
    Thromb Haemost; 2003 Mar; 89(3):409-19. PubMed ID: 12624622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability.
    Guo M; Breslin JW; Wu MH; Gottardi CJ; Yuan SY
    Am J Physiol Cell Physiol; 2008 Apr; 294(4):C977-84. PubMed ID: 18287330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.